Sastasundar Ventures Ltd is Rated Strong Sell

12 hours ago
share
Share Via
Sastasundar Ventures Ltd is rated Strong Sell by MarketsMojo, with this rating last updated on 17 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Sastasundar Ventures Ltd is Rated Strong Sell

Current Rating and Its Significance

The Strong Sell rating assigned to Sastasundar Ventures Ltd indicates a cautious stance for investors, suggesting that the stock currently exhibits significant risks and challenges that outweigh potential rewards. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. It serves as a guide for investors to reconsider exposure to the stock, especially given its microcap status and the healthcare services sector dynamics.

Quality Assessment: Below Average Fundamentals

As of 22 May 2026, Sastasundar Ventures Ltd’s quality grade remains below average. The company continues to report operating losses, which undermines its long-term fundamental strength. The latest financial results show a significant contraction in profitability, with the Profit After Tax (PAT) for the nine months ending December 2025 declining by 85.39% to ₹12.52 crores. This sharp fall in earnings highlights ongoing operational challenges and a lack of sustainable profit generation.

Moreover, the company’s Return on Equity (ROE) stands at zero, reflecting an inability to generate returns on shareholders’ capital. This lack of profitability and weak fundamental metrics contribute heavily to the negative quality assessment, signalling caution for investors seeking stable earnings growth.

Valuation: Very Expensive Relative to Peers

Despite the weak fundamentals, the stock trades at a premium valuation. As of today, the Price to Book Value ratio is 1.3, which is considered very expensive given the company’s flat financial performance and operating losses. This valuation premium is notable because it exceeds the average historical valuations of its peers in the healthcare services sector.

The stock’s elevated valuation, combined with deteriorating profitability, suggests that the market may be pricing in expectations that have yet to materialise. Investors should be wary of paying a premium for a company whose earnings have fallen by 74.6% over the past year, despite the stock delivering a modest 6.08% return during the same period.

Financial Trend: Flat and Challenging

The financial trend for Sastasundar Ventures Ltd is currently flat, indicating stagnation rather than growth. The company’s quarterly non-operating income is unusually high, at 1,480.43% of Profit Before Tax (PBT), which points to reliance on non-core activities rather than sustainable operational earnings. This reliance on non-operating income can mask underlying business weaknesses and is a red flag for investors focused on core profitability.

Additionally, the company’s flat results in December 2025 reinforce the lack of momentum in its financial performance. The absence of growth and persistent losses suggest that the company faces structural challenges that may take time to resolve.

Technical Outlook: Mildly Bearish Sentiment

From a technical perspective, the stock exhibits a mildly bearish trend. Recent price movements show mixed returns: a 5.85% gain over the past month contrasts with declines of 4.68% over the past week and 10.39% over six months. Year-to-date, the stock is down 3.28%, reflecting investor uncertainty and lack of clear upward momentum.

This technical profile aligns with the overall cautious stance suggested by the Strong Sell rating, indicating that the stock may face resistance in reversing its downward trajectory in the near term.

Additional Market Insights

Despite its microcap status, Sastasundar Ventures Ltd has negligible holdings by domestic mutual funds, which currently hold 0% of the company. Given that mutual funds typically conduct thorough on-the-ground research, their absence may signal discomfort with the company’s valuation or business prospects at current price levels.

Investors should consider this lack of institutional interest as an additional factor when evaluating the stock’s risk profile.

Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!

  • - Complete fundamentals package
  • - Technical momentum confirmed
  • - Reasonable valuation entry

Add to Your Radar Now →

What This Rating Means for Investors

For investors, the Strong Sell rating on Sastasundar Ventures Ltd serves as a cautionary signal. It suggests that the stock currently carries elevated risks due to weak operational performance, expensive valuation, stagnant financial trends, and a lack of technical strength. Investors should carefully assess their risk tolerance and consider whether the company’s prospects align with their portfolio objectives.

Given the company’s microcap status and the healthcare services sector’s competitive environment, the stock may be more vulnerable to market volatility and operational setbacks. Those holding the stock might consider reviewing their positions, while prospective investors should seek clear signs of fundamental improvement before committing capital.

Summary of Key Metrics as of 22 May 2026

- Mojo Score: 21.0 (Strong Sell)
- Market Capitalisation: Microcap
- Quality Grade: Below Average
- Valuation Grade: Very Expensive
- Financial Grade: Flat
- Technical Grade: Mildly Bearish
- 1-Year Return: +6.08%
- Profit After Tax (9M Dec 2025): ₹12.52 crores, down 85.39% YoY
- Price to Book Value: 1.3
- ROE: 0%

In conclusion, while Sastasundar Ventures Ltd remains a player in the healthcare services sector, its current financial and market indicators justify the Strong Sell rating. Investors should monitor the company’s future earnings reports and market developments closely to identify any turnaround signals.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News